Merck (MRK) concluded the recent trading session at $110.18, signifying a -1.7% move from its prior day's close.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $144.12, ...

Wells Fargo analysts presented their “Core” list of stocks. These are high-quality, “blue chip, industry-leading companies.” ...

Merck (MRK) is one of the worst-performing stocks in the Dow Jones Industrial Average (DJIA) on Thursday. The US government ...

Shares of Merck Merck & Co. Inc. and Intel Intel Corp. have contributed to the blue-chip gauge's intraday decline, as the Dow Dow Jones Industrial Average was most recently trading 290 points, or 0.7% ...

Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.

The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we ...